Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 505.87M P/E - EPS this Y 25.40% Ern Qtrly Grth -
Income -223.67M Forward P/E -1.99 EPS next Y 5.90% 50D Avg Chg -14.00%
Sales 159.63M PEG - EPS past 5Y - 200D Avg Chg -28.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -56.00%
Recommedations 2.80 Quick Ratio 0.35 Shares Outstanding 21.57M 52W Low Chg 14.00%
Insider Own 1.28% ROA -21.04% Shares Float 21.28M Beta 1.36
Inst Own 41.65% ROE - Shares Shorted/Prior 2.92M/2.65M Price 1.45
Gross Margin -25.07% Profit Margin -139.99% Avg. Volume 5,074,324 Target Price 9.75
Oper. Margin -128.43% Earnings Date Nov 5 Volume 3,487,658 Change -0.68%
About Agenus Inc.

Agenus Inc., a clinical-stage biotechnology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The company also develops Balstilimab, an anti-PD-1 antagonist that has completed Phase II clinical trial to treat second line cervical cancer; AGEN1181, an antigen 4 (CTLA-4) blocking antibody that is in Phase 2 clinical trial for the treatment of pancreatic cancer and and melanoma; AGEN2373, a CD137 monospecific antibody that is in Phase 1b clinical trial; AGEN1423, a CD73/TGFß TRAP antibody; AGEN1571, an ILT2 monospecific antibody that is in Phase 1 clinical trial; and BMS-986442, a TIGIT bispecific antibodies. In addition, it develops INCAGN1876, a GITR agonist; INCAGN2390, a TIM-3 monospecific antibody; INCAGN2385, a LAG-3 monospecific antibody; MK-4830, a monospecific antibody targeting ILT4 that is in Phase 2 clinical trial; UGN-301, a zalifrelimab intravesical solution for the treatment of cancers of the urinary tract that is in a Phase 1 clinical trial; and AGEN1884, a first-generation anti-CTLA-4 monospecific antibody. The company operates under Agenus, MiNK, Prophage, Retrocyte Display, and Stimulon trademarks. It has collaborations with Bristol-Myers Squibb Company, Betta Pharmaceuticals Co., Ltd., Incyte Corporation, Merck Sharpe & Dohme, and Gilead Sciences, Inc. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

Agenus Inc. News
11/19/24 Agenus (AGEN) Loses -41.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
11/18/24 Agenus (AGEN) Loses -41.13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
11/15/24 Down -39.39% in 4 Weeks, Here's Why Agenus (AGEN) Looks Ripe for a Turnaround
11/13/24 Q3 2024 Agenus Inc Earnings Call
11/13/24 Agenus Inc (AGEN) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges While ...
11/12/24 Agenus (AGEN) Q3 2024 Earnings Call Transcript
11/12/24 Agenus (AGEN) Reports Q3 Loss, Lags Revenue Estimates
11/12/24 Agenus: Q3 Earnings Snapshot
11/12/24 Agenus Reports Third Quarter 2024 Financial Results and Strategic Advancements in BOT/BAL Development
11/07/24 Agenus to Present Compelling Data on Botensilimab and AGEN1721 at SITC 2024
11/05/24 Agenus to Provide Third Quarter 2024 Financial Report and Corporate Update
09/13/24 Botensilimab/Balstilimab Clinical Responses in Refractory Sarcomas Presented at ESMO 2024
09/09/24 Agenus Sued by Shareholder for Misleading Investors Over Colorectal Cancer Immuno-Therapy Trial Results
09/09/24 Botensilimab/Balstilimab Clinical Activity in Refractory Sarcomas to be Presented in Oral Session at ESMO 2024
09/03/24 Agenus to Participate in September Investor Conferences
08/08/24 Agenus (AGEN) Q2 2024 Earnings Call Transcript
08/08/24 Agenus (AGEN) Reports Q2 Loss, Lags Revenue Estimates
08/08/24 Agenus: Q2 Earnings Snapshot
08/08/24 Agenus Reports Second Quarter 2024 Operational and Financial Results
08/08/24 Agenus Announces Appointment of Tom Harrison to Board of Directors
AGEN Chatroom

User Image AnalRetort Posted - 4 hours ago

$AGEN Marty makary is a solid pick for this company. Former Panc oncology surgeon who likely is aware of bot and it's potential.

User Image Shoupy Posted - 9 hours ago

$AGEN hHahHhHahahahhahhaa. For 20% in a week on $200k! Boom! I love this stock. Thought I was down, but nope. I will be back on big when it dips again.

User Image Stocksrunner Posted - 9 hours ago

Comeback Queens of the Day! These stocks started down but ROARED back to close higher! $NA $OMER $VUZI $SINT $AGEN From tech to biotech, these names reversed the trend and finished strong!

User Image manny11419 Posted - 10 hours ago

$AGEN Apparently, the company is bouncing off an oversold technical condition, too early to know if its self sustaining, not even close to BV...and only a fraction of MV...lets see if the momentum continues next week.

User Image MrWiseMan Posted - 10 hours ago

$AGEN watch it drop to $2.50 by Tuesday next week. Lol

User Image Amessagefromtheodd Posted - 11 hours ago

$AGEN At the casino 🎰 stock!!!

User Image ajwinner81 Posted - 12 hours ago

$AGEN I mean it’s worth buying now because you will either lose it all or literally win huge (don’t need a lot to gain big on this one)

User Image MrWiseMan Posted - 14 hours ago

$AGEN many are getting trapped today.

User Image PharmaExpert Posted - 15 hours ago

$AKBA, $VRPX, $IMNN, $AGEN, $HSDT πŸ”₯πŸ”₯πŸ”₯πŸ”₯πŸ”₯

User Image biominer Posted - 15 hours ago

$AGEN Wait until Monday. If the momentum holds, it could be a good opportunity to re-enter.

User Image DenariusBuy Posted - 15 hours ago

$AGEN good time to re-enter

User Image DoctorBombay25 Posted - 15 hours ago

$AGEN Cautiously

User Image joanna1993 Posted - 15 hours ago

any reason why this is actually going up? pump maybe? $AGEN

User Image MrWiseMan Posted - 1 day ago

$AGEN see you at $2 losers.

User Image Samishere Posted - 1 day ago

$AGEN When will they finally send Garo to,,,,

User Image MrWiseMan Posted - 1 day ago

$AGEN still waiting for the low low. Watch for $2 buy.

User Image neversurrender2024 Posted - 1 day ago

$AGEN got atm? thats all garos got.. get ready for todays dump.....

User Image neversurrender2024 Posted - 1 day ago

$AGEN 2 board members go quietly in the night a couple of top executives go quitely in the night one of garos spin drs gone quietly in the night garos lead counsel went quietly in the night law suits and and sec investigation? when will garo go quietly in the night????

User Image neversurrender2024 Posted - 2 days ago

$AGEN what ever happended to board member Allison Jeynes? the one garo paid $250k for services from her company avillion life sciences?

User Image weichsel1 Posted - 2 days ago

". Represents a one-time retention award comprised of options to purchase common stock, which were granted to certain key employees, including our executive officers. These options were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan and will vest on November 15, 2025." $AGEN

User Image weichsel1 Posted - 2 days ago

NO, Garo got OPTIONS for 600,000 at exercise price of 2.77, as a retention bonus. To keep him working for the company. On another note Point72 and Deep Track have sold down to zero and 0.1 percent respectively.. (Garo acquired about 6,000 shares at 2.72, which might be his regular salary.) $AGEN

User Image Biotechguy21 Posted - 2 days ago

$AGEN pos only give you negative news. πŸ€‘πŸ€‘πŸ€‘πŸ‘‡πŸ‘‡πŸ‘‡πŸ‘‡πŸ‘‡

User Image docBNM Posted - 2 days ago

$AGEN we need significant news. Like a buyout or some sort of approval.

User Image neversurrender2024 Posted - 2 days ago

$AGEN garo 600k shares @ $2.77... nice to see the snake averaging down on your dime...... honorable mention to mz giggles....300k shares @ $2.77 on your dime... greedy people all in the name of curing cancer....

User Image weichsel1 Posted - 2 days ago

$AGEN Temporary bottom? We are GREEN so far today? Up 2 percent..

User Image TheLearnerEarner Posted - 3 days ago

$AGEN βœ… HUGELY UNDERVALUED stock swing trade - healthcare - micro cap - 4/9 F-Score - 1.23x relative volume - 1x analyst buy rating - superb intrinsic value potential - trading at good value compared to peers and industry - short to medium term gains πŸ“ˆ RSI: 16.96 (oversold heavily) πŸ“Šβš“ Analysts Price Target: $9.00 - $18.90 (244% - 647% above Price) 🌟 Range (12m) $2.52 - $19.69 πŸ’° NEWSDESK (article idea is for AGEN only) πŸ“° https://uk.finance.yahoo.com/news/agenus-agen-loses-41-13-143506733.html

User Image TheLearnerEarner Posted - 3 days ago

$AGEN βœ… HUGELY UNDERVALUED stock swing trade - healthcare - micro cap - 4/9 F-Score - 1.22x relative volume - 1x analyst buy rating - superb intrinsic value potential - trading at good value compared to peers and industry - short to medium term gains πŸ“ˆ RSI: 17.00 (oversold heavily) πŸ“Š Analysts Price Target: $9.00 - $18.90 (244% - 647% above Price) 🌟 Range (12m) $2.52 - $19.69 πŸ’° NEWSDESK (article idea is for AGEN only) πŸ“° https://uk.finance.yahoo.com/news/agenus-agen-loses-41-13-143506733.html

User Image Hopsfarmer Posted - 3 days ago

$AGEN wow these boards can be informative at times, it’s interesting the negativity! I too feel that way at times. But I can tell u that Ulf resigning board. Silence for 3 months, not sugarcoating earnings and stock option grants says there is some sort of deal is imminent. People naturally love negative thoughts, but get some perspective folks. Stock option grants of that size say it all.

User Image 11thestate Posted - 3 days ago

$AGEN stockholders filed a claim against Agenus for misleading them about the potential success of its cancer immunotherapy trials. You can join this case to be notified about potential recovery: https://11thestate.com/cases/agenus-investor-suit

User Image Biotechguy21 Posted - 3 days ago

$AGEN drip drip until BK for this pos πŸ˜‚πŸ˜‚πŸ€‘πŸ€‘πŸ‘€πŸ‘€

Analyst Ratings
B. Riley Securities Buy Aug 14, 24
Jefferies Hold Jul 19, 24
HC Wainwright & Co. Neutral Jul 18, 24
HC Wainwright & Co. Buy Jun 28, 24
HC Wainwright & Co. Buy May 24, 24
HC Wainwright & Co. Buy May 7, 24
B. Riley Securities Buy Mar 18, 24
HC Wainwright & Co. Buy Mar 14, 24
HC Wainwright & Co. Buy Aug 8, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
O'Day Steven J Chief Medical Office.. Chief Medical Officer Jan 04 Sell 3.06 38,679 118,358 61,321 01/06/22